Loading company details...
Beta
Latest Form 4 (Jun 24, 2026): Mark A. Wan (Director): Grant/Award of 5,100 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 24, 2026 | Mark A. Wan | Grant/Award | 5,100 | n/a |
| Jun 24, 2026 | Joseph Todisco | Grant/Award | 5,100 | n/a |
| Jun 24, 2026 | Abhinav Jain | Grant/Award | 5,100 | n/a |
| Jun 24, 2026 | Stephen J. Hoffman | Grant/Award | 5,100 | n/a |
| Jun 24, 2026 | Jill Marie Broadfoot | Grant/Award | 5,100 | n/a |
| Jun 24, 2026 | Marina Bozilenko | Grant/Award | 5,100 | n/a |
| Jun 24, 2026 | Adrian Adams | Grant/Award | 5,100 | n/a |
| May 21, 2026 | Shakil Aslam, Chief Medical Officer | Tax Withholding | 4,518 | $3.7K |
| Apr 3, 2026 | Vincent J. Angotti, CHIEF EXECUTIVE OFFICER | Tax Withholding | 9,938 | $7.2K |
| Apr 3, 2026 | Raffi Asadorian, Chief Financial Officer | Tax Withholding | 2,444 | $1.8K |